Autologous and allogeneic bone marrow transplantation for chronic lymphocytic leukemia: preliminary results von KHOURI, I. F, KEATING, M. J, IPPOLITI, C, MARSHALL, M, THOMAS, M. W, O'BRIEN, S, ROBERTSON, L. E, DEISSEROTH, A. B, CHAMPLIN, R. E, VRIESENDORP, H. M, READING, C. L, PRZEPIORKA, D, HUH#, Y. O, ANDERSSON, B. S, VAN BESIEN, K. W, MEHRA, R. C, GIRALT, S. A

Volltext

Survival of patients with resistant Hodgkin's disease after polyclonal yttrium 90-labeled antiferritin treatment von HERPST, J. M, KLEIN, J. L, LEICHNER, P. K, QUADRI, S. M, VRIESENDORP, H. M

Volltext

Allogeneic blood or marrow transplantation for chronic lymphocytic leukaemia: timing of transplantation and potential effect of fludarabine on acute graft‐versus‐host disease von Khouri, Issa F., Przepiorka, Donna, Van Besien, Koen, O'Brien, Susan, Palmer, Judy L., Lerner, Susan, Mehra, Rakesh C., Vriesendorp, Huibert M., Andersson, Borje S., Giralt, Sergio, Körbling, Martin, Keating, Michael J., Champlin, Richard E.

Volltext

Phase I-II studies of yttrium-labeled antiferritin treatment for end-stage Hodgkin's disease, including Radiation Therapy Oncology Group 87-01 von Vriesendorp, H M, Herpst, J M, Germack, M A, Klein, J L, Leichner, P K, Loudenslager, D M, Order, S E

Volltext

Yttrium 90-labeled antiferritin followed by high-dose chemotherapy and autologous bone marrow transplantation for poor-prognosis Hodgkin's disease von BIERMAN, P. J, VOSE, J. M, LEICHNER, P. K, QUADRI, S. M, ARMITAGE, J. O, KLEIN, J. L, ABRAMS, R. A, DICKE, K. A, VRIESENDORP, H. M

Volltext

GROWTH IN CHILDREN AFTER BONE-MARROW TRANSPLANTATION - BUSULFAN PLUS CYCLOPHOSPHAMIDE VERSUS CYCLOPHOSPHAMIDE PLUS TOTAL-BODY IRRADIATION von WINGARD, PLOTNICK, LP, FREEMER, CS, ZAHURAK, M, PIANTADOSI, S, MILLER, DF, VRIESENDORP, HM, YEAGER, AM, SANTOS, GW

Volltext

Radiolabeled immunoglobulin therapy in patients with Hodgkin's disease von VRIESENDORP, Huib M, QUADRI, Syed M

Volltext

High-dose cytotoxic therapy and bone marrow transplantation for relapsed Hodgkin's disease von Jones, R J, Piantadosi, S, Mann, R B, Ambinder, R F, Seifter, E J, Vriesendorp, H M, Abeloff, M D, Burns, W H, May, W S, Rowley, S D

Volltext

Indium-111-and Yttrium-90-Labeled Human Monoclonal Immunoglobulin M Targeting of Human Ovarian Cancer in Mice von Borchardt, Paul E, Quadri, Syed M, Freedman, Ralph S, Vriesendorp, Huibert M

Volltext

Preclinical analysis of radiolabeled anti‐GD2 immunoglobulin G von Vriesendorp, Francine J., Quadri, Syed M., Flynn, Robyn E., Malone, Michael R., Cromeens, Douglas M., Stephens, L. Clifton, Vriesendorp, Huibert M.

Volltext

Intraperitoneal radioimmunotherapy with human monoclonal IGM in nude mice with peritoneal carcinomatosis von BORCHARDT, P. E, QUADRI, S. M, FREEDMAN, R. S, VRIESENDORP, H. M

Volltext

Liver Toxicity Induced by Combined External-Beam Irradiation and Radioimmunoglobulin Therapy von Wang, S., Quadri, S. M., X-Z. Tang, Stephens, L. C., Lollo, C. P., Bartholomew, R. M., Vriesendorp, H. M.

Volltext

Etoposide, cyclophosphamide, total-body irradiation, and allogeneic bone marrow transplantation for hematologic malignancies von Giralt, S A, LeMaistre, C F, Vriesendorp, H M, Andersson, B S, Dimopoulos, M, Gajewski, J, Van Besien, K, Mehra, R, Przepiorka, D, Khouri, I

Volltext

Selection of reagents for human radioimmunotherapy von Vriesendorp, H.M., Quadri, S.M., Stinson, R.L., Onyekwere, O.C., Shag, Y., Klein, J.L., Leichner, P.K., Williams, J.R.

Volltext

Recurrence of hodgkin's disease after indium‐111 and yttrium‐90 labeled antiferritin administration von Vriesendorp, Huibert M., Quadri, Syed M., Andersson, Borje S., Wyllie, Cynthia T., Dicke, Karel A.

Volltext

Allogeneic bone marrow transplantation for patients with high-risk acute lymphoblastic leukemia von Wingard, J R, Piantadosi, S, Santos, G W, Saral, R, Vriesendorp, H M, Yeager, A M, Burns, W H, Ambinder, R F, Braine, H G, Elfenbein, G

Volltext

Future analyses of total body irradiation von Vriesendorp, H.M., Herman, M.G., Saral, R.

Volltext

A review of the intravenous administration of radiolabeled immunoglobulin G to cancer patients. High or low protein dose? von VRIESENDORP, Huib M, VRIESENDORP, Francine J

Volltext

Fractionated Radiolabeled Antiferritin Therapy for Patients with Recurrent Hodgkin's Disease von Vriesendorp, H M, Quadri, S M, Wyllie, C T, Lai, J, Borchardt, P E, Harris, L, Wucher, R, Askew, E, Schweichler, L

Volltext

Interstitial pneumonitis following autologous bone marrow transplantation von WINGARD, J. R, SOSTRIN, M. B, VRIESENDORP, H. M, MELLITS, E. D, SANTOS, G. W, FULLER, D. J, BRAINE, H. G, YEAGER, A. M, BURNS, W. H, SARAL, R

Volltext